| Thyroid hormone receptor beta induces a tumor-suppressive program in anaplastic thyroid cancer EL Bolf, NE Gillis, CD Davidson, PD Rodriguez, L Cozzens, JA Tomczak, ... Molecular Cancer Research 18 (10), 1443-1452, 2020 | 17 | 2020 |
| Thyroid hormone receptor beta inhibits PI3K-Akt-mTOR signaling axis in anaplastic thyroid cancer via genomic mechanisms CD Davidson, EL Bolf, NE Gillis, LM Cozzens, JA Tomczak, FE Carr Journal of the Endocrine Society 5 (8), bvab102, 2021 | 12 | 2021 |
| Common tumor‐suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells EL Bolf, NE Gillis, CD Davidson, LM Cozzens, S Kogut, JA Tomczak, ... Molecular carcinogenesis 60 (12), 874-885, 2021 | 8 | 2021 |
| A thyroid hormone receptor beta specific agonist suppresses anaplastic thyroid cancer cell phenotype and increases efficacy of therapeutic agents NE Gillis, CD Davidson, LM Cozzens, E Wilson, EL Bolf, JA Tomczak, ... bioRxiv, 2021.06. 09.447689, 2021 | 2 | 2021 |
| TRβ Agonism Induces Tumor Suppression and Enhances Drug Efficacy in Anaplastic Thyroid Cancer in Female Mice NE Gillis, LM Cozzens, ER Wilson, NM Smith, JA Tomczak, EL Bolf, ... Endocrinology 164 (10), bqad135, 2023 | | 2023 |
| Selective Activation of the Thyroid Hormone Receptor Beta (TRβ) Induces Tumor Suppression and Increases Efficacy of Therapeutic Agents N Gillis, L Cozzens, E Wilson, J Tomczak, E Bolf, F Carr | | 2021 |
| Thyroid hormone receptor beta inhibits the PI3K-Akt-mTOR signaling axis in anaplastic thyroid CD Davidson, EL Bolf, NE Gillis, LM Cozzens, JA Tomczak, FE Carr | | 2021 |
| OR21-03 Determining Novel Therapeutic Targets Using an in Vitro Model of TRb Tumor Suppression in Anaplastic Thyroid Cancer NE Gillis, EL Bolf, C Davidson, L Cozzens, J Tomczak, JB Lian, S Frietze, ... Journal of the Endocrine Society 4 (Supplement_1), OR21-03, 2020 | | 2020 |
